Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal

INTRODUCTION: Prothrombin complex concentrate (PCC) and recombinant Factor VIIa (rFVIIa) have been used for emergent reversal of warfarin anticoagulation. Few clinical studies have compared these agents in warfarin reversal. We compared warfarin reversal in patients who received either 3 factor PCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Scott A, Irwin, Eric D, Abou-Karam, Nada M, Rupnow, Nichole M, Hutson, Katherine E, Vespa, Jeffrey, Roach, Robert M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996494/
https://www.ncbi.nlm.nih.gov/pubmed/24731393
http://dx.doi.org/10.1186/1749-7922-9-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996494/
https://www.ncbi.nlm.nih.gov/pubmed/24731393
http://dx.doi.org/10.1186/1749-7922-9-27

Ejemplares similares